New UCLA research finds that 30% of people treated for COVID-19 developed Post Acute Sequelae of COVID-19 (PASC), most commonly known as “Long COVID.” People with a history of hospitalization, diabetes, and higher body mass index were most likely to develop the condition, while those covered by Medicaid, as opposed to commercial health insurance, or had undergone an organ transplant were less likely to develop it.
About 30% of COVID patients develop “Long COVID,” UCLA research finds
April 20, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022